Quantumdx Group Limited
Other human health activities · Newcastle Upon Tyne
ActiveUnited KingdomIncorporated 2008Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2024-03-31
IXBRL · 435 source facts · 15 selected values
Not assessedlegacy record
Accounts to 2024-03-31
IXBRL · 435 source facts · 15 selected values
Not assessed
legacy record
- Reporting period
- 2023-04-01 to 2024-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 323
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- IFRS-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_3000_06523152_20240331
- Source archive
- Accounts_Monthly_Data-October2024.zip
Accounts to 2012-03-31
XBRL · 64 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2012-03-31
XBRL · 64 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- — to —
- Extraction status
- Legacy / not assessed
- Numeric facts
- 41
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-ae-2008-04-06.xsd
- Currency
- GBP
- Source identifier
- Prod224_9984_06523152_20120331
- Source archive
- Accounts_Monthly_Data-November2012.zip
Registered details
06523152- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2008-03-04
- Jurisdiction
- —
- Registered office
- LUGANO BUILDING, 57 MELBOURNE STREET, NEWCASTLE UPON TYNE, NE1 2JQ, ENGLAND
Classification
1 SIC codes86900
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
5 matched grantsCapture-XT, a Novel TB Diagnostic for Indian HealthcareLead
Innovate UK · Collaborative R&D · 2019-10-01 – 2021-02-28
£168,690
awarded
University of Northumbria at Newcastle and QuantuMDx Group LimitedInnovate UK · Knowledge Transfer Partnership · 2018-04-01 – 2020-03-31 · with 1 other participant
University of Northumbria at Newcastle and QuantuMDx Group Limited
Innovate UK · Knowledge Transfer Partnership · 2018-04-01 – 2020-03-31 · with 1 other participant
University of Northumbria at Newcastlelead£91,578
QuantuMDx Group Limited—
GCRF: The PRECISE (PREgnancy Care Integrating translational Science, Everywhere) Network: a sub-Saharan network for placental disordersGCRF · Research Grant · 2017-09-30 – 2022-03-30 · with 18 other participants£7,921,897whole project
GCRF: The PRECISE (PREgnancy Care Integrating translational Science, Everywhere) Network: a sub-Saharan network for placental disorders
GCRF · Research Grant · 2017-09-30 – 2022-03-30 · with 18 other participants
£7,921,897
whole project
King'S College LondonleadAgnes HealthCentre for Sexual Health and HIV AIDS Research Zimbabwe (CeSHHAR Zimbabwe)École des Hautes Etudes en Santé PubliqueGovernment of MozambiqueInstituto de Salud Global de BarcelonaIntelligent UltrasoundLionsGate TechnologiesLion's Head Global PartnersManhiça Health Research Centre (CISM)Microlife (International)Oxford Computer ConsultantsPenn State UniversityQuansys BiosciencesQuantumdx Group LimitedRoche PharmaceuticalsUniversity of Cape TownUniversity of MichiganUniversity of the Witwatersrand
Q-TB: Rapid, cheap POC diagnostic and drug susceptibility testing for human tuberculosisLeadInnovate UK · Collaborative R&D · 2013-10-01 – 2016-03-31 · with 1 other participant£712,674awarded
Q-TB: Rapid, cheap POC diagnostic and drug susceptibility testing for human tuberculosisLead
Innovate UK · Collaborative R&D · 2013-10-01 – 2016-03-31 · with 1 other participant
£712,674
awarded
QuantuMDx Group Ltdlead£712,674
St George's University of London£210,588
Q-CANCER: development of a sample to result device for low cost, rapid tumour profilingLeadInnovate UK · Collaborative R&D · 2013-07-01 – 2016-06-30 · with 3 other participants£752,685awarded
Q-CANCER: development of a sample to result device for low cost, rapid tumour profilingLead
Innovate UK · Collaborative R&D · 2013-07-01 – 2016-06-30 · with 3 other participants
£752,685
awarded
QuantuMDx Group Ltdlead£752,685
University of Newcastle£363,797